Investing News: Three Ways to Invest in Biotech

Back Bay’s Managing Partner and CEO, Jonathan Gertler, was quoted in InvestingNews.com’s article on ways to look at biotech investing, especially with product development often taking decades

.In the article Jonathan told US News that biotech investors need to focus on the “wisdom of the regulatory plan or clinical plan, unmet need in the space [where the company is] attacking and how disrupting or clinically positive the outcome might be.”